Safety and efficacy of procainamide infusions

Koch-Weser, 1969, Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction, N Engl J Med, 218, 1253, 10.1056/NEJM196912042812301 Koch-Weser, 1972, Correlation of serum concentrations and pharmacological effects of antiarrhythmic drugs, 69 Stearns, 1952, Value and hazards of intravenous procainamide therapy, JAMA, 148, 360, 10.1001/jama.1952.02930050032007 Berry, 1951, The use of pronestyl in treatment of ectopic rhythms: 98 episodes in 78 patients, Am J Med, 11, 431, 10.1016/0002-9343(51)90178-7 Epstein, 1953, Ventricular standstill during intravenous procainamide treatment of ventricular tachycardia, Am Heart J, 45, 898, 10.1016/0002-8703(53)90137-9 Schwartz, 1976, The antiarrhythmic activity of intravenous procainamide, 67 Giardina, 1973, Intermittent intravenous procainamide to treat ventricular arrhythmias, Ann Intern Med, 78, 183, 10.7326/0003-4819-78-2-183 Scheinman, 1974, Electrophysiologic effects of procainamide in patients with intraventricular conduction delay, Circulation, 49, 522, 10.1161/01.CIR.49.3.522 Josephson, 1974, Electrophysiologic properties of procainamide in man, Am J Cardiol, 33, 596, 10.1016/0002-9149(74)90248-3 Ghazi, 1974, Effect of loading dose of procaine amide on left ventricular performance in man, Chest, 66, 269, 10.1378/chest.66.3.269 Lima, 1978, Pharmacokinetic approach to intravenous procainamide therapy, Eur J Clin Pharmacol, 13, 303, 10.1007/BF00716367 Killip, 1967, Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients, Am J Cardiol, 20, 457, 10.1016/0002-9149(67)90023-9 Lima, 1978, Micromethod for procainamide and its acetylated metabolite by high performance liquid chromatography Lima, 1978, Determination of procainamide acetylator status, Clin Pharmacol Ther, 23, 25, 10.1002/cpt197823125 Reidenberg, 1975, Polymorphic acetylation of procainamide in man, Clin Pharmacol Ther, 17, 722, 10.1002/cpt1975176722 Strong, 1975, Pharmacokinetics in man of the N-acetylated metabolite of procainamide, J Pharmacokinet Biopharm, 3, 223, 10.1007/BF01066919 Lima JJ, Conti DR, Goldfarb AL, Tilstone WJ, Golden LH, Jusko WJ: Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. J Pharmacokinet Biopharm, in press Koch-Weser, 1971, Procainamide dosage schedules, plasma concentrations and clinical effects, JAMA, 215, 1454, 10.1001/jama.1971.03180220036006 Bigger, 1972, Arrhythmias and antiarrhythmic drugs, Adv Intern Med, 18, 251 Galeazzi, 1976, Relationship between the pharmacokinetics and pharmacodynamics of procainamide, Clin Pharmacol Ther, 20, 278, 10.1002/cpt1976203278 Campbell, 1976, Acetylator phenotype and the clinical pharmacology of slow release procainamide, Br J Clin Pharmacol, 3, 1023, 10.1111/j.1365-2125.1976.tb00352.x Dutcher, 1977, Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology, Clin Pharmacol Ther, 22, 447, 10.1002/cpt1977224447 Henningsen, 1975, Effects of long-term treatment with procainamide, Acta Med Scand, 198, 472 Woosley, 1978, Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome, N Engl J Med, 298, 1157, 10.1056/NEJM197805252982101 Lee, 1977, Antiarrhythmic efficacy of N-acetyl procainamide in patients with premature ventricular contractions, Clin Pharmacol Ther, 19, 508, 10.1002/cpt1976195part1508 Atkinson, 1977, Dose-ranging trial of N-acetyl procainamide in patients with premature ventricular contractions, Clin Pharmacol Ther, 21, 575, 10.1002/cpt1977215575 Evans, 1960, Genetic control of isoniazid metabolism in man, Br Med J, 2, 485, 10.1136/bmj.2.5197.485 Ellard, 1976, Pharmacokinetics of isoniazid metabolism in man, J Pharmacokinet Biopharm, 4, 83, 10.1007/BF01086149 Olson, 1978, Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators, Clin Pharmacol Ther, 23, 204, 10.1002/cpt1978232204 Talseth, 1977, Kinetics of hydralazine elimination, Clin Pharmacol Ther, 21, 715, 10.1002/cpt1977216715 Graffner, 1975, Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man, J Pharmacokinet Biopharm, 3, 69, 10.1007/BF01066016